When John Jumper got the call earlier this month from the Royal Swedish Academy of Sciences that he was winning the Nobel Prize, he almost didn’t answer. The director of Google DeepMind, the tech ...
In five years since AlphaFold's debut, it has transformed basic biochemical research. But its long-term effect on drug discovery remains unclear.
Dailymotion on MSN
AI just found monkeypox’s hidden weakness — a game-changer for vaccines
Artificial intelligence just helped scientists uncover a hidden weakness in the monkeypox virus — a surface protein no one ...
Researchers at Google DeepMind have developed AlphaFold 3, an AI model that can predict the structure of and interactions between biological molecules including proteins, DNA and RNA, and small ...
They build our bodies and orchestrate the molecular processes in cells that keep them healthy. They also present a wealth of targets for new medications. From everyday pain relievers to sophisticated ...
Google Deepmind has unveiled the third major version of its “AlphaFold” artificial intelligence model, designed to help scientists design drugs and target disease more effectively. In 2020, the ...
Google DeepMind cofounder and CEO Demis Hassabis and John Jumper, a senior researcher at the company, shared the 2024 Nobel Prize for Chemistry for their work on AlphaFold, an AI model that predicts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results